Clarifying transfusion-associated graft-versus-host disease risk in modern Hodgkin lymphoma survivorship.

Christin B. DeStefano; Jeremy Perkins; Wendy Cozen; James Long

doi:10.1111/trf.70242

← 뒤로

Clarifying transfusion-associated graft-versus-host disease risk in modern Hodgkin lymphoma survivorship.

1/5 보강

Transfusion 2026 Lymphoma Diagnosis and Treatment

OpenAlex 토픽 · Lymphoma Diagnosis and Treatment Hematopoietic Stem Cell Transplantation Viral-associated cancers and disorders

DeStefano CB, Perkins J, Cozen W, Long J

원문 ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

BibTeX ↓ RIS ↓

APA Christin B. DeStefano, Jeremy Perkins, et al. (2026). Clarifying transfusion-associated graft-versus-host disease risk in modern Hodgkin lymphoma survivorship.. Transfusion. https://doi.org/10.1111/trf.70242

MLA Christin B. DeStefano, et al.. "Clarifying transfusion-associated graft-versus-host disease risk in modern Hodgkin lymphoma survivorship.." Transfusion, 2026.

PMID 42023685

DOI 10.1111/trf.70242